Fine-Needle Cytology and Flow Cytometry Assessment of Reactive and Lymphoproliferative Processes of the Breast

2012 ◽  
Vol 56 (2) ◽  
pp. 130-138 ◽  
Author(s):  
Elena Vigliar ◽  
Immacolata Cozzolino ◽  
Laura Virginia Sosa Fernandez ◽  
Leda Di Pietto ◽  
Albina Riccardi ◽  
...  
2009 ◽  
Vol 117 (3) ◽  
pp. 174-184 ◽  
Author(s):  
Pio Zeppa ◽  
Immacolata Cozzolino ◽  
Anna Lucia Peluso ◽  
Giancarlo Troncone ◽  
Antonio Lucariello ◽  
...  

2008 ◽  
Vol 49 (6) ◽  
pp. 1212-1213
Author(s):  
Giovanni D'Arena ◽  
Nicola Cascavilla ◽  
Maria Napolitano ◽  
Gaetano Corazzelli ◽  
Franco Fulciniti

2016 ◽  
Vol 60 (4) ◽  
pp. 372-384 ◽  
Author(s):  
Anna Lucia Peluso ◽  
Antonio Ieni ◽  
Chiara Mignogna ◽  
Pio Zeppa

Lymph node (LN) fine-needle cytology (FNC) coupled with flow cytometry immunophenotyping provides relevant information for the diagnosis of non-Hodgkin lymphoma (NHL). Numerous studies have shown FNC samples to be suitable for different molecular procedures; in this review, some of the molecular procedures most commonly employed for NHL are briefly described and evaluated in this perspective. Fluorescence in situ hybridization and chromogenic in situ hybridization are briefly described. Polymerase chain reaction (PCR)-based assays are used to identify and quantify mutations and translocations, namely immunoglobulin (IGH) and T-cell receptor rearrangements by clonality testing and IGVH somatic hypermutations either by Sanger sequencing, single-strand conformational polymorphisms or RT-PCR strategies. High-throughput technologies (HTT) encompass numerous and different diagnostic tools that share the capacity of multiple molecular investigation and sample processing in a fast and reproducible manner. HTT includes gene expression profiling, comparative genomic hybridization, single-nucleotide polymorphism arrays and next-generation sequencing technologies. A brief description of these tools and their potential application to LN FNC is reported. The challenge for FNC will be to achieve new knowledge and apply new technologies to FNC, exploiting its own basic qualities.


Cancer ◽  
2003 ◽  
Vol 102 (1) ◽  
pp. 55-65 ◽  
Author(s):  
Pio Zeppa ◽  
Gilda Marino ◽  
Giancarlo Troncone ◽  
Franco Fulciniti ◽  
Amalia De Renzo ◽  
...  

2016 ◽  
Vol 60 (4) ◽  
pp. 302-314 ◽  
Author(s):  
Immacolata Cozzolino ◽  
Monia Rocco ◽  
Giancarlo Villani ◽  
Marco Picardi

In the last decades, lymph node fine-needle cytology (FNC), coupled with flow cytometry (FC), has gained a role in the diagnosis and classification of non-Hodgkin lymphoma (NHL). The combination of FNC/FC allows the diagnosis and classification of NHL in lymph node samples with a high sensitivity and specificity by combining cytological features and specific phenotypic profiles. The present review provides a brief technical description of FC and a detailed analysis of the current markers and their combinations (diagnostic algorithm) for the diagnosis and classification of NHL. The basic principles of clonality assessment, as well as the diagnostic strengths and weaknesses of the procedure, are reported. The current diagnostic algorithms for NHL classification are critically reviewed with a focus on specific problems related to single entities. Moreover, this review provides a detailed analysis of the different clinical contexts in which FNC/FC is performed and related implications. Future and further applications of FNC/FC for NHL are also discussed.


2010 ◽  
Vol 39 (9) ◽  
pp. 681-685 ◽  
Author(s):  
Franco Fulciniti ◽  
Luciano Pezzullo ◽  
Maria Grazia Chiofalo ◽  
Daniela Butera ◽  
Nunzia Simona Losito ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document